Frontlight ResearchEarly access
Trial site
Ashford Cancer Centre Research
- 7running trials
- 5closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Prostate cancer5 trials
- Metastatic breast cancer3 trials
- Bladder cancer1 trial
- Ovarian cancer1 trial
- Pancreatic cancer1 trial
- Sarcoma1 trial
- Phase
- Phase 38 trials
- Phase 2/32 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Active, not recruiting6 trials
- Completed3 trials
- Terminated2 trials
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company3 trials
- Boehringer Ingelheim1 trial
- Daiichi Sankyo1 trial
- EMD Serono Research & Development Institute, Inc.1 trial
- Hinova Pharmaceuticals USA, Inc.1 trial
- and 5 more
Running trials
Active, not recruiting
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Pancreatic cancer1 recruiting
Closed trials
Terminated
Completed
Terminated
HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026